Fusion Antibodies plc (FAB.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.9M |
| Enterprise Value | 5.56M |
| P/E Ratio | -6.77 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 7.65 |
| Price/Book Ratio | 15.2 |
| Enterprise/Revenue | 7.91 |
| Enterprise/EBITDA | -9.25 |
Fiscal Year
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | -0.92 |
| Operating Margin | -1.19 |
AD
Management Effectiveness
| Return On Assets | -0.81 |
| Return On Equity | -2.1 |
Income Statement
| Revenue | 1.97M |
| Revenue/Share | 0.01 |
| Gross Profit | 430,000 |
| EBITDA | -1.62M |
| Net Income | -1.71M |
| Diluted EPS | -0.02 |
Balance Sheet
| Total Cash | 252,000 |
| Total Cash/Share | 0 |
| Total Debt | 671,000 |
| Total Debt/Equity | 0.92 |
| Current Ratio | 1.8 |
| Book Value Per Share | 0.01 |
Price History
| 52-Week Change | -7.14 |
| 52-Week High | 21 |
| 52-Week Low | 9 |
| Moving Average 50 Days | 11.62 |
| Moving Average 200 Days | 13.23 |
Statistics
| Average Volume | 378,020 |
| Shares Outstanding | 125.16M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
